Filing Details

Accession Number:
0001214659-20-010704
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-28 20:00:50
Reporting Period:
2020-12-23
Accepted Time:
2020-12-28 20:00:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1581280 Twist Bioscience Corp TWST Biological Products, (No Disgnostic Substances) (2836) 462058888
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753655 M. Emily Leproust C/O Twist Bioscience Corporation
681 Gateway Blvd.
South San Francisco CA 94080
President & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-23 4,300 $169.14 429,359 No 4 S Direct
Common Stock Disposition 2020-12-23 700 $170.33 428,659 No 4 S Direct
Common Stock Acquisiton 2020-12-24 5,300 $5.95 433,959 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2020-12-24 5,300 $0.00 5,300 $5.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
95,699 2025-09-28 No 4 M Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 16, 2020.
  2. Represents the weighted average sales price per share. The shares sold at prices ranging from $169.00 to $169.49 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  3. Represents the weighted average sales price per share. The shares sold at prices ranging from $170.15 to $170.43 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  4. The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.